Methanobactin – an agent against Wilson’s disease
21 June 2016 | By Victoria White, Digital Content Producer
In an experimental model of Wilson's disease, the peptide, called methanobactin, has already proven superior to conventional medicines...
List view / Grid view
News
Nanoparticles used to deliver RNAi agents to thyroid cancer tumours
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed an innovative nanoplatform that allows them to effectively deliver RNAi agents to the sites of cancer and suppress tumour growth...
F2G raises $60m to develop novel antifungal therapies
20 June 2016 | By Victoria White, Digital Content producer
F2G Ltd has raised $60 million in financing to develop its pipeline of novel therapies to treat life threatening invasive fungal infections...
Mironid secures £4.3 million in Series A funding
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
Researchers identify the molecular mechanism of thalidomide
20 June 2016 | By Victoria White, Digital Content Producer
The new findings on thalidomide, from researchers at the Technical University of Munich (TUM), are highly relevant to current cancer therapies...
Cell Medica and Baylor to co-develop next generation cellular immunotherapies
17 June 2016 | By Victoria White, Digital Content Producer
Cell Medica has entered into a co-development partnership with Baylor to develop technologies for engineering immune cells with enhanced functions...
Researchers identify interactions between immune system pathways
17 June 2016 | By Victoria White, Digital Content Producer
Researchers have identified interactions between immune system pathways which could improve the treatment of diseases such as inflammatory bowel disease...
Tri-I TDI expands focus to include antibody drug discovery
17 June 2016 | By Victoria White, Digital Content Producer
Tri-I TDI will extend its current relationship with Takeda from the realm of small molecule discovery into the new research area of antibody drug discovery...
Gut bacteria reverses autism-related social behaviour in mice
16 June 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that the absence of one specific species of gut bacteria causes autism-related social deficits in mice...
Investigating cancer resistance in naked mole-rats
16 June 2016 | By Victoria White, Digital Content Producer
Researchers believe understanding the anti-cancer mechanisms of naked mole-rats may help advance human treatment in the future...
Super-resolution microscopy reveals the surface of T cells
16 June 2016 | By Victoria White, Digital Content Producer
Salk Institute researchers have imaged how vital receptors on the surface of T cells bundle together when activated using super-resolution microscopy...
The impact of antibiotic exposure on the infant microbiome
15 June 2016 | By Victoria White, Digital Content Producer
An analysis of changes in the intestinal microbial population during the first three years of life has revealed some of the impacts of antibiotic exposure...
A powerful new method for finding drug candidates
15 June 2016 | By Victoria White, Digital Content Producer
Scientists from The Scripps Research Institute have developed a powerful new method for finding drug candidates that bind to specific proteins...
GlobalData analyses the Zika virus vaccine race
15 June 2016 | By Victoria White, Digital Content Producer
The development of a vaccine against the Zika virus should be viewed in the context of tackling all mosquito-borne diseases, according to GlobalData...
Prospective biobank studies can help improve drug development
15 June 2016 | By Victoria White, Digital Content Producer
According to a study, genetic research in large-scale prospective biobank studies can significantly improve the drug development pipeline and reduce costs...
